Chinese Drugmakers Target Expiring U.S. Patents

Law360, New York (November 18, 2003, 12:00 AM EST) -- Chinese drugmakers are targeting expiring U.S. drug patents in a bid to accelerate their expansion plans, the South China Morning Post reported.

Imitating their Indian counterparts, the Chinese firms view acquiring expiring life-sciences technology and over-the-counter drug patents from U.S. companies a more time-efficient option than developing new drugs.

U.S. makers of branded drugs have hesitated to enter the Chinese market given the widespread intellectual property rights violations in the country.

Last week, international agencies including WHO began a three-day meeting in Hanoi to try to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.